首页> 生物试剂> 其他生物试剂> 其他> EGFR (ERBB1) L861Q 10 UG,PV3873,Invitrogen

EGFR (ERBB1) L861Q 10 UG,PV3873,Invitrogen

市场价: 询价 / 套
在线询价
优    惠: 请询价
订货号 6GP9620
品牌型号 Invitrogen PV3873
货期 询货期
最小订货量 1套
联系我们
  • 400-920-3909
  • 商品介绍
  • 规格参数
  • 包装参数
产品介绍 Product Description
规格
Accession Number: NP_005219.2; L861Q
Assay Entry: Biochemical binding/kinetic, Biochemical terbium phospho-specific activity, Biochemical europium phospho-specific activity
Kinase Group: Tyrosine Kinases
Mass: 10 µg
Protein Form: Recombinant, Cytoplasmic
Research Category: Oncology, Signal Transduction
Shipping Condition: Dry Ice
Species: Human
System Compatibility: LanthaScreen® Antibody, LanthaScreen® Substrate, Zin-LYTE™, Omnia® Bulk Substrate
Tag Position: N-Terminal
Target Entry: EGFR L861Q
Target Gene: Epidermal growth factor receptor
Gene ID (Entrez): 114294, 1956
Molecular Weight: 90.5 kDa
Protein Subtype: Receptor Tyrosine Kinases
Gene Alias: EGFR (ErbB1) L861Q
Validated Application: Kinase Assay
Protein Family: Kinases & Inhibitors
Expression System: Baculovirus
KinaseFamily: EGF Receptor (ErbB) Kinase Family
Protein Length: aa 668-1210: L858R, aa 668-1210; L861Q
Protein Tag: GST Tag
储存
Storage Buffer: 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.02% Triton X-100, 2 mM DTT, 50% glycerol
Store at -80°C. At first use, aliquot and store at -80°C to avoid multiple freeze-thaws.
描述

The epidermal growth factor receptor is a receptor tyrosine kinase that signals in response to various growth factors. Overexpression has been linked to numerous types of cancer and EGFR is the target of both biological and small molecular therapeutics. The EGFR L861Q mutation is an Iressa-responsive mutant observed in the clinic.

长度(mm)
宽度(mm)
高度(mm)
重量(kg)
猜你喜欢

在线
客服

在线客服服务时间:09:00-18:00

客服
热线

400-920-3909
客服服务热线 周一至周五(09:00-18:00)

微信
咨询

微信小程序 7X24小时在线咨询